Neoral in liver transplantation. 1996

N V Jamieson, and L Tan, and I Jamieson, and A Trull, and A E Gimson, and G Alexander, and P J Friend, and R Y Calne
Department of Surgery, Addenbrooke's Hospital, Cambridge, UK.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004304 Dosage Forms Completed forms of the pharmaceutical preparation in which prescribed doses of medication are included. They are designed to resist action by gastric fluids, prevent vomiting and nausea, reduce or alleviate the undesirable taste and smells associated with oral administration, achieve a high concentration of drug at target site, or produce a delayed or long-acting drug effect. Dosage Form,Form, Dosage,Forms, Dosage
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015337 Multicenter Studies as Topic Works about controlled studies which are planned and carried out by several cooperating institutions to assess certain variables and outcomes in specific patient populations, for example, a multicenter study of congenital anomalies in children. Multicenter Trials,Multicentre Studies as Topic,Multicentre Trials,Multicenter Trial,Multicentre Trial,Trial, Multicenter,Trial, Multicentre,Trials, Multicenter,Trials, Multicentre
D016031 Liver Transplantation The transference of a part of or an entire liver from one human or animal to another. Grafting, Liver,Hepatic Transplantation,Liver Transplant,Transplantation, Hepatic,Transplantation, Liver,Hepatic Transplantations,Liver Grafting,Liver Transplantations,Liver Transplants,Transplant, Liver
D016572 Cyclosporine A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed). Cyclosporin A,Ciclosporin,CsA-Neoral,CyA-NOF,Cyclosporin,Cyclosporine A,Neoral,OL 27-400,Sandimmun,Sandimmun Neoral,Sandimmune,CsA Neoral,CsANeoral,CyA NOF,OL 27 400,OL 27400

Related Publications

N V Jamieson, and L Tan, and I Jamieson, and A Trull, and A E Gimson, and G Alexander, and P J Friend, and R Y Calne
April 1996, Transplantation proceedings,
N V Jamieson, and L Tan, and I Jamieson, and A Trull, and A E Gimson, and G Alexander, and P J Friend, and R Y Calne
August 1996, Transplantation proceedings,
N V Jamieson, and L Tan, and I Jamieson, and A Trull, and A E Gimson, and G Alexander, and P J Friend, and R Y Calne
August 1996, Transplantation proceedings,
N V Jamieson, and L Tan, and I Jamieson, and A Trull, and A E Gimson, and G Alexander, and P J Friend, and R Y Calne
January 1997, Transplantation proceedings,
N V Jamieson, and L Tan, and I Jamieson, and A Trull, and A E Gimson, and G Alexander, and P J Friend, and R Y Calne
August 1996, Transplantation proceedings,
N V Jamieson, and L Tan, and I Jamieson, and A Trull, and A E Gimson, and G Alexander, and P J Friend, and R Y Calne
January 2001, Transplantation proceedings,
N V Jamieson, and L Tan, and I Jamieson, and A Trull, and A E Gimson, and G Alexander, and P J Friend, and R Y Calne
December 1995, Therapeutic drug monitoring,
N V Jamieson, and L Tan, and I Jamieson, and A Trull, and A E Gimson, and G Alexander, and P J Friend, and R Y Calne
December 1998, Transplantation,
N V Jamieson, and L Tan, and I Jamieson, and A Trull, and A E Gimson, and G Alexander, and P J Friend, and R Y Calne
November 1998, Transplantation proceedings,
N V Jamieson, and L Tan, and I Jamieson, and A Trull, and A E Gimson, and G Alexander, and P J Friend, and R Y Calne
August 1998, Transplantation proceedings,
Copied contents to your clipboard!